Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-21 5:42 pm Sale | 2024-12-31 | 13G | Omeros Corporation OMER | INGALLS & SNYDER LLC | 4,161,315 7.200% | -269,873 (-6.09%) | Filing History |
| 2025-02-21 5:37 pm Purchase | 2024-12-31 | 13G | DURECT Corporation DRRX | INGALLS & SNYDER LLC | 2,681,770 8.500% | 123,758 (+4.84%) | Filing History |
| 2025-02-21 5:23 pm Sale | 2024-12-31 | 13G | Corcept Therapeutics Incorporated CORT | INGALLS & SNYDER LLC | 8,173,721 7.800% | -88,755 (-1.07%) | Filing History |
| 2025-02-21 3:41 pm Purchase | 2024-12-31 | 13G | Stratus Properties Inc. STRS | INGALLS & SNYDER LLC | 1,092,084 13.500% | 111,027 (+11.32%) | Filing History |
| 2025-02-14 5:17 pm Sale | 2024-12-31 | 13G | Applied Energetics, Inc. AERG | INGALLS & SNYDER LLC | 18,158,048 8.200% | -422,188 (-2.27%) | Filing History |
| 2024-03-27 3:15 pm Purchase | 2023-12-31 | 13G | DURECT Corporation DRRX | INGALLS & SNYDER LLC | 2,558,012 8.600% | 2,558,012 (New Position) | Filing History |
| 2024-03-27 3:12 pm Sale | 2005-12-31 | 13G | Stratus Properties Inc. STRS | INGALLS & SNYDER LLC | 981,057 12.300% | -126,983 (-11.46%) | Filing History |
| 2024-03-27 2:47 pm Purchase | 2023-12-31 | 13G | Omeros Corporation OMER | INGALLS & SNYDER LLC | 4,431,188 7.000% | 299,395 (+7.25%) | Filing History |
| 2024-03-27 2:43 pm Sale | 2023-12-31 | 13G | Applied Energetics, Inc. AERG | INGALLS & SNYDER LLC | 18,580,236 8.800% | -6,477,729 (-25.85%) | Filing History |
| 2024-03-27 2:32 pm Purchase | 2023-12-31 | 13G | Corcept Therapeutics Incorporated CORT | INGALLS & SNYDER LLC | 8,262,476 8.000% | 1,172,106 (+16.53%) | Filing History |
| 2024-02-27 10:33 am Purchase | 2024-02-13 | 13G | ImmunoPrecise Antibodies Ltd. IPA | INGALLS & SNYDER LLC | 1,317,819 5.010% | 264,633 (+25.13%) | Filing History |
| 2023-07-07 3:22 pm Purchase | 2023-06-29 | 13D | ImmunoPrecise Antibodies Ltd. IPA | INGALLS & SNYDER LLC | 1,053,186 4.220% | 1,053,186 (New Position) | Filing History |
| 2023-02-17 5:11 pm Sale | 2005-12-31 | 13G | Stratus Properties Inc. STRS | INGALLS & SNYDER LLC | 1,108,040 13.500% | -51,026 (-4.40%) | Filing History |
| 2023-02-17 5:07 pm Sale | 2022-12-31 | 13G | Omeros Corporation OMER | INGALLS & SNYDER LLC | 4,131,793 6.600% | -332,699 (-7.45%) | Filing History |
| 2023-02-17 4:59 pm Purchase | 2022-12-31 | 13G | Corcept Therapeutics Incorporated CORT | INGALLS & SNYDER LLC | 7,090,370 6.600% | 434,393 (+6.53%) | Filing History |
| 2023-02-17 4:49 pm Purchase | 2022-12-31 | 13G | Applied Energetics, Inc. AERG | INGALLS & SNYDER LLC | 25,057,965 12.100% | 8,193,861 (+48.59%) | Filing History |
| 2022-02-04 07:22 am Purchase | 2021-12-31 | 13G | Applied Energetics, Inc. AERG | INGALLS & SNYDER LLC | 16,864,104 8.100% | 16,864,104 (New Position) | Filing History |
| 2022-02-04 07:17 am Sale | 2005-12-31 | 13G | Stratus Properties Inc. STRS | INGALLS & SNYDER LLC | 1,159,066 14.000% | -80,830 (-6.52%) | Filing History |
| 2022-02-04 07:14 am Sale | 2021-12-31 | 13G | Omeros Corporation OMER | INGALLS & SNYDER LLC | 4,464,492 7.100% | -283,697 (-5.97%) | Filing History |
| 2022-02-04 07:11 am Sale | 2021-12-31 | 13G | Corcept Therapeutics Incorporated CORT | INGALLS & SNYDER LLC | 6,655,977 5.700% | -927,795 (-12.23%) | Filing History |